Evaluation of the safety and efficacy of platelet rich plasma in treatment of patients with chronic telogen effluvium
Not Applicable
- Conditions
- Skin and Connective Tissue Diseases
- Registration Number
- PACTR202006539654415
- Lead Sponsor
- Faculty of Medicine Sohag University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
female patients
chronic telogen effluvium patients (diffuse hair falling more than 6 months)
aged between 18 and 55 years
Exclusion Criteria
?Pregnant and lactating women.
?Patients having any dermatological diseases affecting the scalp.
?Thyroid dysfunction.
?Chronic medical diseases.
?Patients with anemia (hemoglobin level <10mg/dl), thrombocytopenia (platelet count < 100,000 /µL), coagulopathies or patients on anticoagulant therapy as aspirin and patients with iron deficiency.
?Patients received topical or systemic treatment for hair loss in the last three months before the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method